Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Fungal Biol ; 120(2): 147-54, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26781370

ABSTRACT

Ultrastructural features of conidia, lateral walls of aerial and submerged hyphal cells, and of septal pore apparatus of Scedosporium apiospermum, S. boydii, Pseudallescheria angusta and Scedosporium aurantiacum were studied. Submerged hyphal cells possessed a thick extracellular matrix. Crystalline satellites accessory to the septal pore apparatus were revealed. Fundamental ultrastructural features appeared to be heterogeneous at low taxonomic levels. The closely interrelated members of the S. apiospermum complex showed quantitative ultrastructural variability, but the unambiguously different species S. aurantiacum deviated qualitatively by markers of conidial wall structure, Woronin bodies morphology and presence/absence of crystalline satellites of the septal pore apparatus.


Subject(s)
Biodiversity , Scedosporium/ultrastructure , Spores, Fungal/ultrastructure , Scedosporium/classification , Scedosporium/isolation & purification , Spores, Fungal/classification , Spores, Fungal/isolation & purification
2.
Mycoses ; 57 Suppl 3: 91-6, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25187314

ABSTRACT

We prospectively observed 36 haematological patients with mucormycosis from nine hospitals of St. Petersburg during 2004-2013. The most frequent underlying diseases were acute leukaemia (64%), and main risk factors were prolonged neutropenia (92%) and lymphocytopenia (86%). In 50% of the patients, mucormycosis was diagnosed 1-65 days after invasive aspergillosis. Main clinical form of mucormycosis was pulmonary (64%), while two or more organ involvement was noted in 50% of the cases. The most frequent aetiological agents of mucormycosis were Rhizopus spp. (48%). Twelve-week survival rate was 50%. Combination therapy (echinocandins + amphotericin B forms) and recovery from the underlying disease significantly improved the survival rate.


Subject(s)
Lymphopenia/microbiology , Mucormycosis/drug therapy , Mucormycosis/epidemiology , Neutropenia/microbiology , Adolescent , Adult , Aged , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Child , Drug Combinations , Echinocandins/therapeutic use , Female , Humans , Lymphopenia/drug therapy , Male , Middle Aged , Neutropenia/drug therapy , Prospective Studies , Rhizopus/classification , Rhizopus/pathogenicity , Risk Factors , Russia/epidemiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...